Farallon Capital Management LLC Cytokinetics Inc Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Farallon Capital Management LLC holds 102,400 shares of CYTK stock, worth $5.06 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

102,400

Previous 102,400 -0.0%

Holding current value

$5.06 Million

Previous $5.55 Million 2.56%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $62.8 Million - $106 Million	-985,372 Reduced 90.59%	102,400 $7.18 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $29.2 Million - $90.8 Million	1,087,772 New	1,087,772 $90.8 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $641,403 - $797,072	21,772 New	21,772 $641,000
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $29.9 Million - $37.3 Million	-916,300 Reduced 97.68%	21,772 $710,000
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $25.5 Million - $34.9 Million	-763,666 Reduced 44.88%	938,072 $33 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $2.89 Million - $4.12 Million	80,700 Added 4.98%	1,701,738 $78 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $24 Million - $34 Million	-624,000 Reduced 27.79%	1,621,038 $78.5 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $12.3 Million - $17.7 Million	362,439 Added 19.25%	2,245,038 $88.2 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $8.56 Million - $13.2 Million	-287,743 Reduced 13.26%	1,882,599 $69.3 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $19.3 Million - $26.1 Million	-562,433 Reduced 20.58%	2,170,342 $98.9 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $2.66 Million - $5.12 Million	-143,225 Reduced 4.98%	2,732,775 $97.7 Million
Q2 2021 Aug 13, 2021	BUY	$19.79 - $26.99 $7.44 Million - $10.1 Million	376,000 Added 15.04%	2,876,000 $56.9 Million
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $1.86 Million - $2.57 Million	100,000 Added 4.17%	2,500,000 $58.2 Million
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $3.82 Million - $7.15 Million	250,000 Added 11.63%	2,400,000 $49.9 Million
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $13.4 Million - $18.8 Million	650,000 Added 43.33%	2,150,000 $46.5 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $9.76 Million - $21.6 Million	875,000 Added 140.0%	1,500,000 $35.4 Million
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $5.47 Million - $10.2 Million	625,000 New	625,000 $7.37 Million

Others Institutions Holding CYTK

# of Institutions

405

Shares Held

125M

Call Options Held

4.61M

Put Options Held

2.46M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.66B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Cytokinetics Inc Transaction History